One-Pager

Aerosol Drugs and Humidity

Humidifiers and HMEs, choosing a nebulizer, mucoactive and inhaled anti-infective drugs, sequence and stopping rules

Reviewed by Alex G, BSN, RN, CEN, CCRN, CMC, NREMT-P · Checked against current sources October 2026

Download one-page PDFLetter landscape, ready to print or keep with your notes

Humidity and humidifiers

Inspired gas reaches 37 °C and 44 mg H₂O/L just below the carina. Humidity deficit = 44 − delivered absolute humidity; an artificial airway bypasses the nose's heat and moisture exchange.

DeviceUseWatch
Bubble humidifierLow-flow O₂; consider above 4 L/minPop-off whistles if tubing kinks
Heated humidifierVentilator, HFNC, NIV33–44 mg/L at 34–41 °C at the Y
Heated-wire circuitLess rainoutDrain condensate away from patient
HMEShort-term ventilation, transportAdds dead space and resistance
Large-volume nebulizerTrach collar, bland aerosolMist must persist on inspiration

Choosing an aerosol generator

Inhaler technique and in-line ventilator delivery: see PFTs and Oxygen Delivery.
DeviceStrengthLimit
Jet nebulizerAny solution; cheap0.5–1 mL left behind; adds flow
Vibrating meshLittle residue; adds no flowCost; never touch the mesh
UltrasonicLarge volume for sputum inductionNot for suspensions or proteins
pMDI with valved chamberFast; equals a nebulizer in asthmaMask under about age 4
Dry powder inhalerNo propellant or spacerNeeds a fast, forceful breath

Mucoactive and bland aerosols

AgentUseKey point
Hypertonic saline 7%CF; non-CF bronchiectasisBronchodilator first
Hypertonic saline 3%Sputum inductionBooth or negative-pressure room
Dornase alfa 2.5 mg dailyCF onlyNever mixed; harmful in non-CF
Acetylcysteine 20%, 3–5 mLThick secretionsBronchospasm: give with albuterol
Sterile water, salineBypassed airway; upper-airway edemaWater can cause bronchospasm

Inhaled anti-infectives and special drugs

DrugRegimenPrecautions
Tobramycin (CF)300 mg twice daily, 28 days on, 28 offLast in the sequence; not mixed
Aztreonam (CF)75 mg three times daily by its own meshBronchodilator first
Pentamidine300 mg every 4 weeks, Respirgard IINegative pressure, filter, TB screen
RibavirinSPAG-2, 12–18 h a dayTeratogenic: scavenge; no pregnant staff
EpoprostenolContinuous mesh on the ventilatorClogs filters; never stop abruptly

Sequence, response and stopping

Practice Aerosol Drugs and Humidity questions free in your browser12 exam-style questions with rationales. No account or download needed.

In depth

The one-page summary above is what the PDF prints. These sections go further.

Humidity physics and troubleshooting

Absolute humidity is the water vapor in a volume of gas (mg/L); relative humidity is that content as a percentage of what the gas could hold at its temperature. Warming a saturated gas lowers its relative humidity, and cooling it causes rainout. At 37 °C, saturated gas holds 44 mg/L, so gas delivered at 30 mg/L leaves a humidity deficit of 14 mg/L that the airway must make up. The isothermic saturation boundary normally sits about 5 cm below the carina; dry gas through a tube moves it deeper, drying mucosa, slowing cilia and thickening secretions until they plug the tube.

AARC 2012 calls for humidification in every invasively ventilated patient: 33–44 mg/L at 34–41 °C at the Y-piece from a heated humidifier, or at least 30 mg/L from an HME, which suits short-term use and transport. Heated-wire circuits keep the inspiratory limb warmer than the chamber so less water condenses; if the circuit runs much hotter than the chamber, relative humidity falls and secretions dry. A probe left inside an incubator or under a radiant warmer reads falsely high and the heater turns down.

ProblemLikely causeFix
Water pooling, coughing with breathsRainout in a cool limbDrain away from patient; check heated wire
Thick, dry secretions on an HMEHumidity too low for this patientChange to a heated humidifier
Rising peak pressure on an HMEHME soaked or blockedReplace it; consider active humidity
Low-temperature alarmEmpty chamber, probe off, new circuitRefill, reseat probe, allow warm-up
Bubble humidifier whistlingKinked or blocked tubingFind the obstruction; never tape the valve

Bland aerosol (AARC 2003) has three indications: cool aerosol for upper-airway edema (post-extubation, subglottic), humidity for a bypassed upper airway, and hypertonic or hypotonic saline for sputum induction. Its only listed contraindication is bronchoconstriction. Aerosol is a poorer humidifier for a tracheostomy than a heated humidifier and carries infection risk. Cool mist for croup is traditional but has shown no benefit in trials.

Aerosol generators in detail

Particles of 1–5 µm reach the lower airways; larger ones impact in the mouth and throat, more so with fast breathing, and smaller ones are often exhaled. Jet nebulizers shear liquid with gas at 6–8 L/min from a 4–5 mL fill and leave 0.5–1 mL in the cup; tapping the cup and treating until it sputters extracts more. Breath-enhanced and breath-actuated designs waste less during exhalation.

Vibrating mesh nebulizers push liquid through a plate with thousands of laser-drilled holes. They are quiet, portable, leave little residue and add no gas, which makes them the usual choice on ventilators and for continuous inhaled epoprostenol; because they are efficient, some doses may need adjusting. Ultrasonic nebulizers vibrate a piezoelectric crystal at 1–3 MHz, can warm and degrade drugs, and should not be used for suspensions such as budesonide or for proteins such as dornase. Large-volume ultrasonic units are used for sputum induction.

Continuous albuterol for severe asthma (EPR-3) is 10–15 mg/h in adults and 0.5 mg/kg/h in children, through a large-volume or infusion-fed mesh nebulizer, with cardiac monitoring and potassium checks. Ipratropium mist in the eyes can dilate the pupil and precipitate angle-closure glaucoma, so use a mouthpiece or a well-fitted mask.

Mucoactive drugs and the evidence

Mucolytics break mucus bonds: acetylcysteine splits disulfide bonds and dornase alfa cleaves the DNA released by neutrophils, which is why dornase works in purulent CF sputum. Hypertonic saline is a hyperosmolar expectorant that draws water into the airway surface liquid and raises mucociliary clearance. Acetylcysteine smells of sulfur, irritates the airway and can cause bronchospasm at any dose, so the label advises a nebulized bronchodilator and stopping if bronchospasm progresses; a vial once opened is refrigerated and used within 96 hours.

The CF Foundation (2013) recommends dornase and 7% hypertonic saline for patients 6 years and older. In idiopathic bronchiectasis, dornase given twice daily for 24 weeks increased exacerbations and FEV₁ decline (O'Donnell 1998, 349 patients), so it is not used outside CF. AARC 2015 found no high-level evidence for any aerosol to aid secretion clearance in hospitalized patients without CF and recommends against routine dornase, acetylcysteine and bronchodilators for that purpose.

For a first Pseudomonas aeruginosa culture in CF, the CF Foundation (2014) recommends inhaled tobramycin for eradication, typically 300 mg twice daily for 28 days. Chronic infection is treated with cycles of inhaled tobramycin or aztreonam, given after airway clearance. Inhaled antibiotics need an expiratory filter in hospital to protect staff, and tobramycin is never mixed with dornase in the cup.

Protecting patients and staff

NBRC emphasis and exam pearls

Practice free in your browser3,800+ exam-style questions with rationales. No account, no ads. Also free on the App Store and Google Play.

Related one-pagers

Sources

  1. National Board for Respiratory Care. The Respiratory Therapy Examination Detailed Content Outline, effective January 2027. Link
  2. Restrepo RD, Walsh BK. Humidification during invasive and noninvasive mechanical ventilation: 2012. Respir Care. 2012;57(5):782-788. Link
  3. American Association for Respiratory Care. AARC Clinical Practice Guideline: Bland aerosol administration, 2003 revision and update. Respir Care. 2003;48(5):529-533. Link
  4. Piraino T, Madden M, Roberts KJ, et al. AARC Clinical Practice Guideline: Management of Adult Patients With Oxygen in the Acute Care Setting. Respir Care. 2022;67(1):115-128. Link
  5. De Vries MJ, Garner SS, Hartley C, Stocking J. Pulmonary Disease Aerosol Delivery Devices: A Guide for Physicians, Nurses, Pharmacists, and Other Health Care Professionals. 4th ed. American Association for Respiratory Care; 2023. Link
  6. Ari A, Restrepo RD. Aerosol delivery device selection for spontaneously breathing patients: 2012. Respir Care. 2012;57(4):613-626. Link
  7. Strickland SL, Rubin BK, Haas CF, et al. AARC Clinical Practice Guideline: Effectiveness of Pharmacologic Airway Clearance Therapies in Hospitalized Patients. Respir Care. 2015;60(7):1071-1077. Link
  8. Mogayzel PJ Jr, Naureckas ET, Robinson KA, et al. Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health. Am J Respir Crit Care Med. 2013;187(7):680-689. Link
  9. Mogayzel PJ Jr, Naureckas ET, Robinson KA, et al. Cystic Fibrosis Foundation pulmonary guideline. Pharmacologic approaches to prevention and eradication of initial Pseudomonas aeruginosa infection. Ann Am Thorac Soc. 2014;11(10):1640-1650. Link
  10. O'Donnell AE, Barker AF, Ilowite JS, Fick RB. Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. Chest. 1998;113(5):1329-1334. Link
  11. Acetylcysteine solution, USP (inhalation). Prescribing information. DailyMed, US National Library of Medicine. Link
  12. Pulmozyme (dornase alfa) inhalation solution. Prescribing information, Genentech. DailyMed. Link
  13. Tobramycin inhalation solution. Prescribing information. DailyMed. Link
  14. Cayston (aztreonam for inhalation solution). Prescribing information, Gilead Sciences. DailyMed. Link
  15. NebuPent (pentamidine isethionate) for inhalation. Prescribing information, Fresenius Kabi. DailyMed. Link
  16. Ribavirin for inhalation solution, USP. Prescribing information. DailyMed. Link
  17. Tablan OC, Anderson LJ, Besser R, et al. Guidelines for preventing health-care-associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep. 2004;53(RR-3):1-36. Link
  18. National Heart, Lung, and Blood Institute. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. 2007. Link
  19. Johnson DW. Croup. Am Fam Physician. 2016;94(6):476-478 (Clinical Evidence Handbook). Link